59 related articles for article (PubMed ID: 22157695)
1. Establishment of a conversion factor for the Cepheid GeneXpert BCR-ABL assay.
McNiven M; Talaulikar D
Pathology; 2012 Jan; 44(1):55-7. PubMed ID: 22157695
[No Abstract] [Full Text] [Related]
2. Evaluation of the Cepheid GeneXpert BCR-ABL assay.
Jobbagy Z; van Atta R; Murphy KM; Eshleman JR; Gocke CD
J Mol Diagn; 2007 Apr; 9(2):220-7. PubMed ID: 17384214
[TBL] [Abstract][Full Text] [Related]
3. Detection of BCR/ABL fusion gene in CML: a preliminary report.
Rerkamnuaychoke B; Kangwanpong D; Jootar S; Puranakanitstha C
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():197-200. PubMed ID: 8629106
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive validation of a real-time quantitative bcr-abl assay for clinical laboratory use.
Jones CD; Yeung C; Zehnder JL
Am J Clin Pathol; 2003 Jul; 120(1):42-8. PubMed ID: 12866371
[TBL] [Abstract][Full Text] [Related]
5. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
Matolcsy A
Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
[TBL] [Abstract][Full Text] [Related]
6. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein.
Wada H; Mizutani S; Nishimura J; Usuki Y; Kohsaki M; Komai M; Kaneko H; Sakamoto S; Delia D; Kanamaru A
Cancer Res; 1995 Jul; 55(14):3192-6. PubMed ID: 7606740
[TBL] [Abstract][Full Text] [Related]
7. Investigation of bcr-abl transcription by Ph-positive chronic myeloid leukemia progenitors.
Keating A
Stem Cells; 1993 Oct; 11 Suppl 3():31-3. PubMed ID: 8298475
[TBL] [Abstract][Full Text] [Related]
8. [Chronic myelogenous leukemia expressing two bcr-abl chimeric mRNA; a case report].
Hashimoto S; Hiyoshi M; Hino M; Yamane T; Ota T; Koh KR; Tagawa S; Tatsumi N
Rinsho Ketsueki; 1997 Jan; 38(1):72-4. PubMed ID: 9028165
[TBL] [Abstract][Full Text] [Related]
9. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
[TBL] [Abstract][Full Text] [Related]
10. Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?
So CC; Wan TS; Yip SF; Ma SK; Lam CC; Chan LC
Br J Haematol; 2007 May; 137(4):377. PubMed ID: 17374140
[No Abstract] [Full Text] [Related]
11. Description of a new BCR-ABL point mutation in a CML patient with evolution to lymphoid blast crisis.
Hokama PO; Capannacci J; Hokama NK; Cliquet MG; Souza MP; Mauad MA; Colturato VA
Leuk Res; 2010 Apr; 34(4):e106-7. PubMed ID: 19931180
[No Abstract] [Full Text] [Related]
12. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
13. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
[TBL] [Abstract][Full Text] [Related]
14. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
[TBL] [Abstract][Full Text] [Related]
15. Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemia.
Todoric-Zivanovic B; Strnad M; Stamatovic D; Tukic L; Krtolica K; Tatomirovic Z; Djordjevic V; Bogdanovic A; Jankovic G; Magic Z
J BUON; 2011; 16(1):104-7. PubMed ID: 21674858
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of chronic myelogenous leukemia.
Bergamaschi G; Rosti V
Haematologica; 1994; 79(1):1-3. PubMed ID: 15378940
[No Abstract] [Full Text] [Related]
17. An atypical (b3/a3) junction of the bcr/abl gene lacking abl exon a2 in a patient with chronic myeloid leukemia.
Amabile M; Martinelli G; Terragna C; Montefusco V; Tabilio A; Tura S
Haematologica; 1999 Jun; 84(6):573-5. PubMed ID: 10366813
[No Abstract] [Full Text] [Related]
18. [Genetic diagnosis of chronic myeloid leukemia].
Kato C; Naoe T
Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
[TBL] [Abstract][Full Text] [Related]
19. [Diversity of BCR and ABL gene breakpoints in chronic myelogenous leukemia].
Sugimoto T
Rinsho Ketsueki; 2003 Feb; 44(2):61-4. PubMed ID: 12692976
[No Abstract] [Full Text] [Related]
20. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]